+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Myelodysplastic Syndrome Market Report 2026 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Leukemia Therapeutics Market Report 2026 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
From
Pediatric Neuroblastoma Treatment Market Report 2026 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Acute Myeloid Leukemia Market Report 2026 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
Loading Indicator